A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer
Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
Multiple Drug Resistance is the phenomena whereby cells become resistant to a variety of
drugs with different mechanisms of action. Drug resistance remains a significant impediment
to successful cancer chemotherapy inhibitors have been developed and are currently in
clinical trials. CBT-1 is a natural product currently in clinical trials as an inhibitor